...
...
Next Story

Covid-19 vaccine update: US approves Moderna candidate, Odisha prepares for inoculation drive

US approved of the second vaccine candidate on Friday, the Moderna Covid-19 vaccine has an efficacy rate of 94.1%. Orissa assessed preparedness for inoculation drive. Elsewhere Colombia inked deals with both Pfizer and Moderna for 20 million vaccine doses.

Updated on: Dec 19, 2020, 09:50:34 IST
Hindustan Times, New Delhi | By
Prefer HTon Google
Advertisement

Countries around the globe are gearing up to vaccinate citizens against the coronavirus disease (Covid-19). The US on Friday approved its second vaccine candidate, Moderna, for emergency use. The European Medicines Agency too is on the final leg of its approval process and is expected to come out with a decision on the Moderna vaccine on January 6, according to Reuters. The global vaccine alliance COVAX saw its member country sign deals for vaccine procurement for emergency use. With the global caseload nearing 75 million the world is racing against time to immunize its population against a virus that has been wreaking havoc for more than a year now.

US regulator Food and Drug Administration (FDA) has given approval to the Moderna vaccine for emergency use (REUTERS)
US regulator Food and Drug Administration (FDA) has given approval to the Moderna vaccine for emergency use (REUTERS)

Here are the latest updates on the Covid-19 vaccine front:

1. US regulator Food and Drug Administration (FDA) has given approval to the Moderna vaccine for emergency use. This is the second approval for an inoculation drive in the United States and the first for Moderna. Data released by Moderna on November 30 of the late-stage trial shows that the vaccine has an efficiency rate of 94.1%, according to Reuters. Both Canada and the European Medicines Agency (EMA) are currently slated to come out with their approvals soon.

2. AstraZeneca has started the process of seeking emergency use authorization in Britain and India. According to the data published by the pharmaceutical giant of the late-stage trial, their vaccine has an efficacy rate of 70% and as much as 90% for a subgroup of trial participants who were given a half dose first, followed by a full dose, reported Reuters. India is currently conducting an accelerated review and has asked for more data.

4. The Odisha government has completed its database collection for the first phase of Covid-19 inoculation, reported news agency ANI on Saturday. The government has identified 3.2 lakh healthcare workers who are eligible for emergency vaccination. They have also demarcated 8,267 vaccinators and 29,276 centres to help carry out the vaccination process. For storage purposes, the state has assessed a total of 1,222 cold chain points across the state and readied 1,796 Ice Lined Refrigerators (ILRs) for transportation and 1,771 deep freezers for safe transportation of the vaccine all across the state, ANI said.

 
Get the latest World News, breaking headlines and global updates from the US, UK, Pakistan, Bangladesh, Russia and other countries. Follow major international events on Hindustan Times.
Get the latest World News, breaking headlines and global updates from the US, UK, Pakistan, Bangladesh, Russia and other countries. Follow major international events on Hindustan Times.
SHARE THIS ARTICLE ON
Hindustantimes wants to start sending you push notifications. Click allow to subscribe